The World Health Organization (WHO) has warned that the current Ebola outbreak in eastern Democratic Republic of Congo (DRC) is progressing so quickly it could surpass the scale of the 2014–2016 West African epidemic.
Current situation and trajectory
According to WHO briefings, the outbreak — caused by the rare Bundibugyo strain of Ebola — has killed more than 2,000 people from in excess of 4,300 confirmed cases. The agency said sequencing indicates the outbreak began in February, although it was formally declared on 15 May.
“At its current pace, it’s on track to eclipse the West African Ebola outbreak of 2014 to 2016,” WHO chief Tedros Adhanom Ghebreyesus said.
For context, the 2014–2016 epidemic resulted in at least 28,000 cases and more than 11,000 deaths. WHO officials describe the present outbreak as the fastest‑growing they have seen and say it began with a considerable head start, complicating containment efforts.
Why containment is proving difficult
WHO and disease control authorities highlighted several structural and operational factors impeding response efforts:
- Geography and infrastructure: The outbreak is centred in remote, poorly connected areas where health centres lack resources.
- Security challenges: Ongoing conflict in parts of eastern DRC restricts safe access for health teams and limits monitoring.
- Workforce constraints: Some health workers have gone on strike over unpaid salaries, further reducing response capacity.
- Community mistrust and misinformation: False information and wariness of outsiders are keeping some affected people away from clinics.
WHO’s director for health emergency alert and response operations, Dr Abdirahman Mahamud, warned that these factors have left the outbreak “way ahead of us” and that the agency and partners are in a race to catch up.
Vaccines, treatments and outlook
The Bundibugyo strain differs from strains in previous major outbreaks: at present there are no approved vaccines or specific treatments for this variant, though WHO reported that two candidate vaccines are being tested.
WHO modelling gives a range for how long the outbreak might continue. Officials said the agency expects the peak within about six months in a moderate scenario, but warned there is a possible one‑case scenario in which the outbreak could last nine to 12 months.
| Item | Figure from WHO reports |
|---|---|
| Cases (reported) | More than 4,300 |
| Deaths (reported) | More than 2,000 |
| 2014–2016 epidemic cases | At least 28,000 |
| 2014–2016 epidemic deaths | More than 11,000 |
Regional risks and South Africa's preparedness
Although the outbreak is centred in eastern DRC, WHO noted that affected areas border South Sudan, Uganda and Rwanda. Cross‑border movement, porous frontiers and population displacement increase the risk of international spread.
South African health authorities should therefore maintain heightened surveillance at points of entry, reinforce rapid diagnostic capacity, review isolation and referral protocols, and ensure clinical staff are briefed on Ebola recognition and infection prevention. Public messaging must counter misinformation and encourage people with symptoms or exposures to seek assessment at clinics rather than self‑manage.
WHO’s public timeline and projections underline that the window for effective intervention is shrinking unless surveillance, community engagement and vaccination trials accelerate.
Practical advice
- If you or someone you know has recently travelled to affected border regions and develops fever, diarrhoea, vomiting or bleeding, seek immediate assessment at a clinic or hospital — do not self‑diagnose.
- Follow public health guidance on hygiene and reporting of suspected cases; avoid close contact with the bodily fluids of someone who is ill.
- Health professionals should keep updated with WHO and national department of health advisories regarding case definitions, personal protective equipment and referral pathways.
WHO and responding partners face a difficult task: halting a rapidly expanding outbreak in insecure terrain while testing candidate vaccines against a strain for which there are no established countermeasures. The outcome will depend on expanded access to affected communities, stronger local health capacity, and rapid uptake of evidence‑based interventions.
Readers with health concerns should consult their nearest clinic or a healthcare professional rather than relying on informal sources of information.
